Skip to main content
Toggle navigation
Login
Home
Favorite
Like
Post
Print
Samantha Martel
Takeda Pharmaceutical Company Limited
Poster(s):
(B-222) Comparison of time-to-next treatment and time-to-event endpoints using real-world data in checkpoint inhibitor-treated patients with advanced non-small cell lung cancer
Monday, August 25, 2025
11:30 AM - 1:00 PM
ET